Prostatype Genomics AB

medical devices

About

Prostatype Genomics offers prostate cancer patients a decision support for the most optimal treatment option! We developed a test system called 'Prostatype® Test System'. The system is based on a gene expression test, which measures the expression of three carefully selected embryonic stem cell genes in prostate cancer core needle biopsies. In conjunction with currently used clinical parameters, the PrTS predicts overall survival in relation to treatment. The Prostatype® Test System helps to choose the optimal treatment strategy for each patient. This secures quality of life for patients with a low risk tumor without jeopardizing safety for patients with aggressive tumors.

Technologies

Outlook Microsoft Office 365 YouTube Wistia Google Tag Manager WordPress.org Open AdStream (Appnexus) Mobile Friendly Vimeo

Keywords

prostate cancer cancer prognosis optimal treatment unnecessary surgery medical equipment manufacturing prognostic gene test oncology diagnostics healthcare resources international studies health economics risk stratification in prostate cancer us market entry ce-marked medical research genomics clinical parameters healthcare efficiency gene panel for prostate cancer precision oncology karolinska institutet medical technology european market commercialization gene expression analysis biomarker development molecular diagnostics personalized medicine clinical validation prostate cancer diagnosis over-treatment clinical decision support

Location

34 Gustav III:s boulevard, Stockholm County, Sweden, 169 73

Related Companies

Companies in the same industry